You Position: Home > Paper

Research progress IL-1β in the mechanism of action and clinical treatment of diabetic retinopathy

( views:8, downloads:6 )
Author:
No author available
Journal Title:
Chinese Journal of Diabetes
Issue:
7
DOI:
10.3969/j.issn.1006-6187.2024.07.015
Key Word:
白介素1β;糖尿病视网膜病变;作用机制;IL-1β;Diabetic retinopathy;Mechanism of action

Abstract: Diabetic retinopathy(DR)is the main cause of blindness and visual impairment.In hyperglycemia,oxidative stress,or hypoxia,IL-1β upregulation mediates retinal inflammation.Sustained low-grade inflammation can cause retinal vascular damage and neurodegeneration,stimulate oxidative damage,disrupt the blood retinal barrier,and induce retinal neovascularization.This article reviews the research progress of IL-1β in the mechanism and clinical treatment of DR.

  • This article has no references!
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn